Morvan syndrome with Caspr2 antibodies. Clinical and autopsy report.
Section of Clinical Neuroscience, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Sweden.
C
C
Sundal
Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
C
C
Vedeler
Department of Pathology, Haukeland University Hospital, Bergen, Norway; Department of Biomedicine, University of Bergen, Bergen, Norway.
H
H
Miletic
Section of Clinical Neuroscience, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Sweden. Electronic address: Oluf.andersen@neuro.gu.se.
O
O
Andersen
D000368:Aged; D001323:Autoantibodies; D001344:Autopsy; D015922:Complement C1q / Q000378:metabolism; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D017493:Leukocyte Common Antigens / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D008297:Male; D008565:Membrane Proteins / Q000276:immunology*; D009419:Nerve Tissue Proteins / Q000276:immunology*; D013595:Syringomyelia / Q000097:blood* / Q000276:immunology*
D001323:Autoantibodies; C403049:CNTNAP2 protein, human; D006684:HLA-DR Antigens; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D015922:Complement C1q; D017493:Leukocyte Common Antigens
Caspr2 antibody; Complement; Immunoglobulin; Morvan syndrome; Neurofibrillary tangles; Neuropathology; VGKC antibody